Literature DB >> 11398196

Transformation of kidney epithelial cells by a quinol thioether via inactivation of the tuberous sclerosis-2 tumor suppressor gene.

H S Yoon1, T J Monks, C L Walker, S S Lau.   

Abstract

Although hydroquinone (HQ) is a rodent carcinogen, because of its lack of mutagenicity in standard bacterial mutagenicity assays it is generally considered a nongenotoxic carcinogen. 2,3,5-Tris-(glutathion-S-yl)HQ (TGHQ) is a potent nephrotoxic metabolite of HQ that may play an important role in HQ-mediated nephrocarcinogenicity. TGHQ mediates cell injury by generating reactive oxygen species and covalently binding to tissue macromolecules. We determined the ability of HQ and TGHQ to induce cell transformation in primary renal epithelial cells derived from the Eker rat. Eker rats possess a germline inactivation of one allele of the tuberous sclerosis-2 (Tsc-2) tumor suppressor gene that predisposes the animals to renal cell carcinoma. Treatment of primary Eker rat renal epithelial cells with HQ (25 and 50 microM) or TGHQ (100 and 300 microM) induced 2- to 4-fold and 6- to 20-fold increases in cell transformation, respectively. Subsequently, three cell lines (The QT-RRE 1, 2, and 3) were established from TGHQ-induced transformed colonies. The QT-RRE cell lines exhibited a broad range of numerical cytogenetic alterations, loss of heterozygosity at the Tsc-2 gene locus, and loss of expression of tuberin, the protein encoded by the Tsc-2 gene. Only heterozygous (Tsc-2(EK/+)) kidney epithelial cells were susceptible to transformation by HQ and TGHQ, as wild-type cells (Tsc-2(+/+)) showed no increase in transformation frequency over background levels following chemical exposure. These data indicate that TGHQ and HQ are capable of directly transforming rat renal epithelial cells and that the Tsc-2 tumor suppressor gene is an important target of TGHQ-mediated renal epithelial cell transformation. Copyright 2001 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11398196     DOI: 10.1002/mc.1037

Source DB:  PubMed          Journal:  Mol Carcinog        ISSN: 0899-1987            Impact factor:   4.784


  7 in total

1.  Utilization of MALDI-TOF to determine chemical-protein adduct formation in vitro.

Authors:  Ashley A Fisher; Matthew T Labenski; Terrence J Monks; Serrine S Lau
Journal:  Methods Mol Biol       Date:  2011

2.  ERK crosstalks with 4EBP1 to activate cyclin D1 translation during quinol-thioether-induced tuberous sclerosis renal cell carcinoma.

Authors:  Jennifer D Cohen; Jaime M C Gard; Raymond B Nagle; Justin D Dietrich; Terrence J Monks; Serrine S Lau
Journal:  Toxicol Sci       Date:  2011-08-02       Impact factor: 4.849

3.  cAMP-dependent cytosolic mislocalization of p27(kip)-cyclin D1 during quinol-thioether-induced tuberous sclerosis renal cell carcinoma.

Authors:  Jennifer D Cohen; Kimberly Y Tham; Nicholas J Mastrandrea; Alfred C Gallegos; Terrence J Monks; Serrine S Lau
Journal:  Toxicol Sci       Date:  2011-06-20       Impact factor: 4.849

4.  Transcriptional and post-translational modifications of B-Raf in quinol-thioether induced tuberous sclerosis renal cell carcinoma.

Authors:  Jennifer D Cohen; Matthew Labenski; Nicholas J Mastrandrea; Ryan D Canatsey; Terrence J Monks; Serrine S Lau
Journal:  Mol Carcinog       Date:  2015-08-31       Impact factor: 4.784

5.  Genotoxicity of 2,6- and 3,5-dimethylaniline in cultured mammalian cells: the role of reactive oxygen species.

Authors:  Ming-Wei Chao; Min Young Kim; Wenjie Ye; Jing Ge; Laura J Trudel; Crystal L Belanger; Paul L Skipper; Bevin P Engelward; Steven R Tannenbaum; Gerald N Wogan
Journal:  Toxicol Sci       Date:  2012-07-24       Impact factor: 4.849

Review 6.  Monocyclic aromatic amines as potential human carcinogens: old is new again.

Authors:  Paul L Skipper; Min Young Kim; H-L Patty Sun; Gerald N Wogan; Steven R Tannenbaum
Journal:  Carcinogenesis       Date:  2009-11-03       Impact factor: 4.944

Review 7.  Crossing paths in Human Renal Cell Carcinoma (hRCC).

Authors:  Guadalupe Aparicio Gallego; Vanessa Medina Villaamil; Enrique Grande; Isabel Santamarina Caínzos; Luís M Antón Aparicio
Journal:  Int J Mol Sci       Date:  2012-10-05       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.